The UK competition watchdog has hit several drug makers with fines totalling more than £260m after they overcharged the NHS for hydrocortisone tablets.
The Competition and Markets Authority (CMA) said on Thursday that pharmaceutical firms Auden Mckenzie and Actavis UK, now known as Accord-UK, used their position as sole providers of the drug to inflate its price for almost a decade.
It said the price of the drugs was increased by 10,000% against the price of the branded drug, under its previous owner, in 2008.
What these pills are used for
Hydrocortisone pills are used by tens of thousands of people across the UK to treat adrenal insufficiency, which includes life-threatening conditions such as Addison’s disease.
Investigations by the CMA found that the amount the NHS had to pay for a single pack of 10mg tablets rose from 70p in April 2008 to £88 by March 2016. Chief executive of the CMA Andrea Coscelli, said:
These are without doubt some of the most serious abuses we have uncovered in recent years,
The actions of these firms cost the NHS – and therefore taxpayers – hundreds of millions of pounds.
The regulator also said that Auden Mckenzie paid off would-be competitors AMCo (now known as Advanz Pharma) and Waymade to stay out of the market.
Actavis UK continued paying off AMCo after taking over sales of hydrocortisone tablets in 2015
Auden Mckenzie’s decision to raise prices for de-branded drugs meant that the NHS had no choice but to pay huge sums of taxpayers’ money for life-saving medicines.
In practice, the NHS was at one point being charged over £80 for a single pack of tablets that had previously cost less than £1.
These were egregious breaches of the law that artificially inflated the costs faced by the NHS, reducing the money available for patient care.
Our fine serves as a warning to any other drug firm planning to exploit the NHS.
The regulator said Accord-UK will be liable for £65.6m of the total fine, while former parent company Allergan should be solely liable for £109.1m. The pair will also be jointly liable for £2m.
Accord-UK, Accord Healthcare and the current parent company Intas are jointly and severally liable for £44.4m, the CMA said.
It added that there is a total fine of £42.8m for AMCo, while Waymade will be required to pay £2.5m.
We need your help to keep speaking the truth
Every story that you have come to us with; each injustice you have asked us to investigate; every campaign we have fought; each of your unheard voices we amplified; we do this for you. We are making a difference on your behalf.
Our fight is your fight. You’ve supported our collective struggle every time you gave us a like; and every time you shared our work across social media. Now we need you to support us with a monthly donation.
We have published nearly 2,000 articles and over 50 films in 2021. And we want to do this and more in 2022 but we don’t have enough money to go on at this pace. So, if you value our work and want us to continue then please join us and be part of The Canary family.
In return, you get:
* Advert free reading experience
* Quarterly group video call with the Editor-in-Chief
* Behind the scenes monthly e-newsletter
* 20% discount in our shop
Almost all of our spending goes to the people who make The Canary’s content. So your contribution directly supports our writers and enables us to continue to do what we do: speaking truth, powered by you. We have weathered many attempts to shut us down and silence our vital opposition to an increasingly fascist government and right-wing mainstream media.
With your help we can continue:
* Holding political and state power to account
* Advocating for the people the system marginalises
* Being a media outlet that upholds the highest standards
* Campaigning on the issues others won’t
* Putting your lives central to everything we do
We are a drop of truth in an ocean of deceit. But we can’t do this without your support. So please, can you help us continue the fight?